Urticaria pigmentosa

International Journal of Dermatology

Volumn 36, Issue 5, 1997, Pages 321-325

  Allison, Matthew A ^a   Schmidt, Christopher P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETAMETHASONE DIPROPIONATE; CIMETIDINE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DOXEPIN; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PSORALEN; RANITIDINE; TRIAMCINOLONE ACETATE;

ADOLESCENT; ADULT; ANIMAL MODEL; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DISEASE CLASSIFICATION; DOUBLE BLIND PROCEDURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY DIAGNOSIS; MAST CELL; MASTOCYTOSIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PROGNOSIS; PRURITUS; PUVA; REVIEW; SKIN DISEASE; TOPICAL DRUG ADMINISTRATION; URTICARIA PIGMENTOSA;

EID: 0030962866     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1997.00029.x     Document Type: Review

References (27)

1. Nettleship E, Tay W. Rare forms of urticaria. Br Med J 1869; 2: 323-324.
2. DiBacco RS, DeLeo VA. Mastocytosis and the mast cell. J Am Acad Dermatol 1982; 7: 709-722.
3. Fine JD. Mastocytosis. Int J Dermatol 1980; 198: 117-123.
4. Caplan RM. The natural course of urticaria pigmentosa. Arch Dermatol 1983; 87: 146-157.
5. Soter NA. The skin in mastocytosis. J Invest Dermatol 1991; 96: 32S-39S.
6. Sagher F, Even-Paz Z. Mastocytosis and the Mast Cell. Chicago: Year Book Medical Publisher Inc., 1967: 1-242.
7. Longley J, Duffy TP, Kohn S. The mast cell and mast cell disease. J Am Acad Dermatol 1995; 32: 545-561.
8. Galli SJ, Iemura A, Garlick DS, et al. Reversible expansion of primate mast cell populations in vivo by stem cell factor. J Clin Invest 1993; 91: 148-152.
9. Stein DH. Mastocytosis: a review. Pediatric Dermatol 1986; 3: 365-375.
10. Demis DJ. The mastocytosis syndrome: clinical and biochemical studies. Ann Int Med 1963; 59: 194-206.
11. Fishman R, Fleming CR, Chen-Yang L. Systemic mastocytosis with review of gastrointestinal manifestations. Mayo Clin Proc 1979; 54: 51-54.
12. Czarnetzki BM, Kolde G, Schoemann A, et al. Bone marrow findings in adult patients with urticaria pigmentosa. J Am Acad Dermatol 1988; 18: 45-51.
13. Awad JA, Morrow JD, Roberts LJ. Detection of the major urinary metabolites of prostaglandin D2 in the circulation: demonstration of elevated levels in patients with disorders of systemic mast cell activation. J All Clin Immunol 1994; 93: 817-824.
14. Granerus G, Lonnqvist B, Roupe G. No relationship between histamine release measured as metabolite excretion in the urine, and serum levels of mast cell specific tryptase in mastocytosis. Agents-Actions 1994; 41: C127-C128.
15. Horny HP, Ruck M, Wehrmann M, Kaiserling E. Blood findings in generalized mastocytosis: evidence of frequent simultaneous occurrence of myeloproliferative disorders. Br J Hematol 1990; 76: 186-193.
16. Parker RI. Hematologic aspects of mastocytosis: I: Bone marrow pathology in adult and pediatric systemic mast cell disease. J Invest Dermatol 1991; 96: 47s-54s.
17. Gerrard JW, Ko C. Urticaria pigmentosa: treatment with cimetidine and chlorpheniramine. J Peds 1979; 94: 843-844.
18. Soter NA, Austen KF, Wasserman SI. Oral disodium cromoglycate in the treatment of systemic mastocytosis. N Engl J Med 1979; 301: 465-469.
19. Roberts LJ, Sweetman BJ, Lewis RA, et al. Increased production of prostaglandin D2 in patients with systemic mastocytosis. N Engl J Med 1984; 303: 1400-1404.
20. James MP. The treatment of urticaria pigmentosa. Clin Exp Dermatol 1982; 7: 311-320.
21. Horan RF, Austen KF. The skin in mastocytosis. J Invest Dermatol 1991; 96: 5S-18S.
22. Norris DA, Capin L, Weston WL. The effect of epicutaneous glucocorticoid on human monocyte and neutrophil migration in vivo. J Invest Dermatol 1982; 78: 386-390.
23. Barton J, Lavker RM, Schechtner NM, Lazarus GS. Treatment of urticaria pigmentosa with corticosteroids. Arch Dermatol 1985; 121: 1516-1523.
24. Roberts LJ, Fields JP, Oates JA. Mastocytosis without urticaria pigmentosa: a frequently unrecognized cause of recurrent syncope. Trans Assoc Am Phys 1982; 95: 36-41.
25. Parker F, Odland GF. The mastocytosis syndrome. In: Fitzpatrick TB, Arndt KA, Clark WH, et al. eds. Dermatology in General Medicine, New York: McGraw-Hill, 1979: 772-783.
26. Lennert K, Parwaresch MR. Mast cells and mast cell neoplasia: a review. Histopathology 1979; 3: 339.
27. Travis WD, Li C, Yam LT, et al. Significance of systemic mast cell disease with associated hematologic disorders. Cancer 1988; 62: 965-972.